Protein kinase C (PKC) and cyclic AMP-dependent protein kinase (PKA) are important for normal cell proliferation. We show that both kinases are down-regulated by a phorbol ester tumor promoter in nontumorigenic murine BALB/c 3T3 fibroblasts (A31 cells), whereas only PKC responded to the phorbol ester in a chemically transformed derivative cell line (DMBA31 cells). In quiescent A31 cells, phorbol dibutyrate (PDBu) caused a 10-fold reduction in PKC activity and a 5-fold reduction in PKA activity. In contrast, PDBu depleted quiescent DMBA31 cells of PKC activity only and had no effect on the PKA activity. In both cell lines, PDBu did not affect the level of PKA regulatory subunits (determined by a cyclic [3H]-AMP binding assay), the levels of mRNA encoding the catalytic and the abundant regulatory subunit (determined by Northern blotting), or the level of the catalytic subunit protein (determined by Western blotting). An in situ gel activity assay confirmed that PDBu reduced the kinase activity of native PKA complexes from A31 cells but not from DMBA31 cells. These results indicate that phorbol esters down-regulate PKA activity by a posttranslational mechanism. They further suggest that the activity of PKC and PKA may be coordinately regulated in nontumorigenic cells and that transformation can disrupt this coordinate regulation.


Supported by Grant CA45695 from the National Cancer Institute.

This content is only available via PDF.